| Literature DB >> 23702256 |
Asmaa Ahmed El-Zaher1, Marianne Alphonse Mahrouse.
Abstract
BACKGROUND: Nifuroxazide (NF) is an oral nitrofuran antibiotic, having a wide range of bactericidal activity against gram positive and gram negative enteropathogenic organisms. It is formulated either in single form, as intestinal antiseptic or in combination with drotaverine (DV) for the treatment of gastroenteritis accompanied with gastrointestinal spasm. Spectrofluorimetry is a convenient and sensitive technique for pharmaceutical quality control. The new proposed spectrofluorimetric method allows its determination either in single form or in binary mixture with DV. Furthermore, experimental conditions were optimized using the new approach: Experimental design, which has many advantages over the old one, one variable at a time (OVAT approach).Entities:
Year: 2013 PMID: 23702256 PMCID: PMC3701539 DOI: 10.1186/1752-153X-7-90
Source DB: PubMed Journal: Chem Cent J ISSN: 1752-153X Impact factor: 4.215
Scheme 1Chemical structures of (a) and (b).
Experimental matrix and experimental plan of the face centered composite design
|
| ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 | 1 | 0 | −1 | −1 | 0.3 | 1.5 | 25 | 10 |
| 2 | 0 | 1 | 1 | 1 | 0.2 | 2.5 | 55 | 30 |
| 3 | 1 | −1 | −1 | 1 | 0.3 | 0.5 | 25 | 30 |
| 4 | 0 | 0 | 0 | 0 | 0.2 | 1.5 | 40 | 20 |
| 5 | −1 | 1 | 0 | −1 | 0.1 | 2.5 | 40 | 10 |
| 6 | −1 | 0 | −1 | 0 | 0.1 | 1.5 | 25 | 20 |
| 7 | 0 | 0 | 0 | 0 | 0.2 | 1.5 | 40 | 20 |
| 8 | 0 | −1 | 1 | 0 | 0.2 | 0.5 | 55 | 20 |
| 9 | 1 | 1 | 1 | −1 | 0.3 | 2.5 | 55 | 10 |
| 10 | −1 | −1 | 0 | 1 | 0.1 | 0.5 | 40 | 30 |
| 11 | 0 | 0 | 0 | 0 | 0.2 | 1.5 | 40 | 20 |
Figure 1Interaction plots for the effect of volume of and volume of HSO(a) and the effect of temperature and heating time (b) on fluorescence intensity.
Estimated regression coefficients and associated probability values ( -value) for fluorescence intensity
| | | ||||
|---|---|---|---|---|---|
| Constant | 159.48 | 0.001 | Constant | 701.72 | 0.000 |
| Volume of EAA | −75.37 | 0.023 | Temperature | 193.67 | 0.000 |
| Volume of sulfuric acid | 145.62 | 0.001 | Heating time | 47.41 | 0.035 |
| Volume of EAA * Volume of EAA | 42.99 | 0.299 | Temperature * Temperature | −203.80 | 0.000 |
| Volume of sulfuric acid * Volume of sulfuric acid | 132.56 | 0.011 | Heating time * Heating time | −2.75 | 0.921 |
| Volume of EAA* Volume of sulfuric acid | −88.28 | 0.028 | Temperature * Heating time | −34.58 | 0.165 |
Figure 2Pareto charts showing the influence of volume of sulfuric acid and volume of EAA (a) and that of temperature and heating time (b) on the fluorescence intensity.
Figure 3Response surface plots (a) and contour plots (b) showing the effect of volume of EAA, volume of sulfuric acid (a, b) and temperature and heating time (a, b) on fluorescence intensity.
Figure 4Normal probability plot, histogram, residuals versus fits and residuals versus order for fluorescence intensity, model 1 (a) and model 2 (b).
Analysis of variance (ANOVA) results for fluorescence intensity
| Regression | 0.002 | Regression | 0.000 |
| Linear | 0.001 | Linear | 0.000 |
| Square | 0.010 | Square | 0.000 |
| Interaction | 0.028 | Interaction | 0.165 |
| Residual error | | Residual error | |
| Lack-of-fit | 0.000 | Lack-of-fit | 0.000 |
Scheme 2Suggested pathway for the reaction between and / HSO.
Figure 5Excitation and emission spectra of the coumarin product produced by reaction between 350 ng mlof and in methanol ( ____ ) and reagent blank (− − − -) (λ= 340 nm, λ= 390 nm ).
Assay parameters and method validation obtained by applying spectrofluorimetric method for the determination of
| Excitation wavelength | 340 nm |
| Emission wavelength | 390 nm |
| Range of linearity | 20 - 400 ng ml-1 |
| Regression equation | y = 1448.447x + 101.590 |
| Correlation coefficient ( | 0.9997 |
| 14.185 | |
| 3.477 | |
| Confidence limit of the slope | 1448.447 ± 45.137 |
| Confidence limit of the intercept | 101.590 ± 11.064 |
| Standard error of the estimation | 4.310 |
| LODa | 0.01 ng ml-1 |
| LOQa | 0.03 ng ml-1 |
| Intradayb | |
| % RSD | 0.692 – 0.598 |
| Interdayc | |
| % RSD | 0.688 – 0.395 |
a Limits of detection and quantification are determined via calculations [29]:
LOD= 3.3×SD/slope LOQ= 10×SD/slope, where SD is standard deviation of response.
b The intraday (n = 3), average of two concentrations of NF (100, 350 ng ml−1), repeated three times within the day.
c The interday (n = 3), average of two concentrations of NF (100, 350 ng ml−1), repeated three times in three successive days.
Application of the proposed spectrofluorimetric method for the determination of in pure samples
| 50 | 49.991 | 99.98 |
| 150 | 150.009 | 100.07 |
| 250 | 250.896 | 100.36 |
| 350 | 347.552 | 99.30 |
| Mean | | 99.93 |
| ± SD | 0.449 |
a Average of three determinations.
Determination of in capsules by the proposed spectrofluorimetric method and application of standard addition technique
| 100 | 99.70 | 80 | 100.11 | 100 | 99.01 | 80 | 100.97 |
| | | 100 | 100.80 | | | 100 | 98.73 |
| | | 120 | 100.68 | | | 120 | 99.53 |
| 150 | 100.53 | 120 | 100.11 | 150 | 100.07 | 120 | 100.11 |
| | | 150 | 100.34 | | | 150 | 100.80 |
| | | 170 | 99.90 | | | 170 | 99.50 |
| 200 | 99.56 | 160 | 98.38 | 200 | 100.25 | 160 | 100.11 |
| | | 180 | 99.72 | | | 180 | 100.87 |
| | | 200 | 99.42 | | | 200 | 99.42 |
| Mean | 99.93 | | 99.94 | | 99.78 | | 100.00 |
| ± SD | 0.524 | 0.730 | 0.670 | 0.773 | |||
a Average of three different determinations.
Statistical analysis of the results obtained by applying the proposed spectrofluorimetric method and the reference method
| Pure form | Mean | 99.93 | 99.28 |
| | SD | 0.449 | 0.745 |
| | RSD | 0.449 | 0.750 |
| | 4 | 5 | |
| | Variance | 0.201 | 0.555 |
| | 0.05 (2.365)* | | |
| | 2.761 (9.12)* | | |
| Antinal® capsules | Mean | 99.93 | 100.49 |
| SD | 0.524 | 0.955 | |
| | RSD | 0.524 | 0.950 |
| | 3 | 5 | |
| | Variance | 0.275 | 0.912 |
| | 1.07 (2.447)* | | |
| 3.316 (19.25)* |
* Figures in parentheses are the corresponding theoretical t -and F-values at p = 0.05.